177 related articles for article (PubMed ID: 11923062)
21. Design and study of ibuprofen disintegrating sustained-release tablets comprising coated pellets.
Abbaspour MR; Sadeghi F; Afrasiabi Garekani H
Eur J Pharm Biopharm; 2008 Mar; 68(3):747-59. PubMed ID: 17977701
[TBL] [Abstract][Full Text] [Related]
22. The preparation of rapidly disintegrating tablets in the mouth.
Sugimoto M; Matsubara K; Koida Y; Kobayashi M
Pharm Dev Technol; 2001 Nov; 6(4):487-93. PubMed ID: 11775950
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of rapidly disintegrating tablets prepared by a direct compression method.
Bi YX; Sunada H; Yonezawa Y; Danjo K
Drug Dev Ind Pharm; 1999 May; 25(5):571-81. PubMed ID: 10219525
[TBL] [Abstract][Full Text] [Related]
24. Application of SeDeM expert systems in preformulation studies of pediatric ibuprofen ODT tablets.
Sipos E; Oltean AR; Szabó ZI; Rédai EM; Nagy GD
Acta Pharm; 2017 Jun; 67(2):237-246. PubMed ID: 28590910
[TBL] [Abstract][Full Text] [Related]
25. A pharmaceutical study on lornoxicam fast disintegrating tablets: formulation and in vitro and in vivo evaluation.
Moutasim MY; ElMeshad AN; El-Nabarawi MA
Drug Deliv Transl Res; 2017 Jun; 7(3):450-459. PubMed ID: 28283842
[TBL] [Abstract][Full Text] [Related]
26. Formulation and evaluation of Cetirizine dihydrochloride orodispersible tablet.
Subramanian S; Sankar V; Manakadan AA; Ismail S; Andhuvan G
Pak J Pharm Sci; 2010 Apr; 23(2):232-5. PubMed ID: 20363705
[TBL] [Abstract][Full Text] [Related]
27. Locust bean gum as superdisintegrant--formulation and evaluation of nimesulide orodispersible tablets.
Malik K; Arora G; Singh I
Polim Med; 2011; 41(1):17-28. PubMed ID: 21739929
[TBL] [Abstract][Full Text] [Related]
28. Formulation and evaluation of rapidly disintegrating fenoverine tablets: effect of superdisintegrants.
Battu SK; Repka MA; Majumdar S; Madhusudan RY
Drug Dev Ind Pharm; 2007 Nov; 33(11):1225-32. PubMed ID: 18058319
[TBL] [Abstract][Full Text] [Related]
29. Formulation development and optimization of Ibuprofen tablets by direct compression method.
Bushra R; Shoaib MH; Aslam N; Hashmat D; Ur-Rehman M
Pak J Pharm Sci; 2008 Apr; 21(2):113-20. PubMed ID: 18390440
[TBL] [Abstract][Full Text] [Related]
30. Preparation and optimization of mouth/orally dissolving tablets using a combination of glycine, carboxymethyl cellulose and sodium alginate: a comparison with superdisintegrants.
Vora N; Rana V
Pharm Dev Technol; 2008; 13(3):233-43. PubMed ID: 18484492
[TBL] [Abstract][Full Text] [Related]
31. Fast-disintegrating sublingual tablets: effect of epinephrine load on tablet characteristics.
Rawas-Qalaji MM; Simons FE; Simons KJ
AAPS PharmSciTech; 2006 Apr; 7(2):E41. PubMed ID: 16796358
[TBL] [Abstract][Full Text] [Related]
32. Anti-inflammatory and pharmacokinetics evaluation of PEGylated ibuprofen tablet formulation.
Mumuni M; Kenechukwu FC; Chime SA; Ogbonna JD; Mora AT
Drug Deliv; 2014 Jun; 21(4):315-9. PubMed ID: 24191762
[TBL] [Abstract][Full Text] [Related]
33. Predicting the critical quality attributes of ibuprofen tablets via modelling of process parameters for roller compaction and tabletting.
Matji A; Donato N; Gagol A; Morales E; Carvajal L; Serrano DR; Worku ZA; Healy AM; Torrado JJ
Int J Pharm; 2019 Jun; 565():209-218. PubMed ID: 31075438
[TBL] [Abstract][Full Text] [Related]
34. Influence of Prosolv and Prosolv:Mannitol 200 direct compression fillers on the physicomechanical properties of atorvastatin oral dispersible tablets.
Gowda V; Pabari RM; Kelly JG; Ramtoola Z
Pharm Dev Technol; 2015 Jun; 20(4):394-400. PubMed ID: 24397821
[TBL] [Abstract][Full Text] [Related]
35. Novel approach of aceclofenac fast dissolving tablet.
Dave V; Yadav S; Sharma S; Vishwakarma P; Ali N
Pak J Pharm Sci; 2015 Jan; 28(1):37-41. PubMed ID: 25553683
[TBL] [Abstract][Full Text] [Related]
36. Preparation and evaluation of swelling induced-orally disintegrating tablets by microwave irradiation.
Sano S; Iwao Y; Kimura S; Itai S
Int J Pharm; 2011 Sep; 416(1):252-9. PubMed ID: 21763765
[TBL] [Abstract][Full Text] [Related]
37. Formulation of a extended release tablet containing dexibuprofen.
Yi HG; Chi MH; Kim YI; Woo JS; Park ES
Arch Pharm Res; 2008 Dec; 31(12):1637-43. PubMed ID: 19099235
[TBL] [Abstract][Full Text] [Related]
38. A pilot human pharmacokinetic study and influence of formulation factors on orodispersible tablet incorporating meloxicam solid dispersion using factorial design.
Aboelwafa AA; Fahmy RH
Pharm Dev Technol; 2012; 17(1):1-14. PubMed ID: 20550483
[TBL] [Abstract][Full Text] [Related]
39. Formulation of Ebastine Fast-Disintegrating Tablet Using Coprocessed Superdisintegrants and Evaluation of Quality Control Parameters.
Dhakal B; Thakur JK; Mahato RK; Rawat I; Rabin DC; Chhetri RR; Shah KP; Adhikari A; Pandey J
ScientificWorldJournal; 2022; 2022():9618344. PubMed ID: 35645632
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of rapidly disintegrating tablets containing glycine and carboxymethylcellulose.
Fukami J; Yonemochi E; Yoshihashi Y; Terada K
Int J Pharm; 2006 Mar; 310(1-2):101-9. PubMed ID: 16434157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
